Arrowhead Pharmaceuticals ( $ARWR ) Declines -25.65% Over 30 Days Despite Strong Clinical Pipeline (See the latest news for any ticker on Tickeron.) Arrowhead Pharmaceuticals (ARWR) fell about 25.65% over the trailing 30 days, from a close of $89.41 to $66.48, despite a steady stream of positive clinical updates. The decline followed a powerful rally, with the stock still up more than 110% over the trailing 12 months, underscoring profit-taking and fading short-term momentum. $AXON $IONS $REPL $AMRN $AVBP